MiR-23b targets cyclin G1 and suppresses ovarian cancer tumorigenesis and progression

Overview of attention for article published in Journal of Experimental & Clinical Cancer Research, February 2016

Altmetric Badge

Mentioned by

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 1,707 followers.

MiR-23b targets cyclin G1 and suppresses ovarian cancer tumorigenesis and progression. https://t.co/ez6rNPJ5QS

MiR-23b targets cyclin G1 and suppresses ovarian cancer tumorigenesis and progression. https://t.co/CL8plCrkbw

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.